BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31476936)

  • 1. Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders.
    Guenther L; Lynde C; Poulin Y
    J Cutan Med Surg; 2019; 23(4_suppl):27S-34S. PubMed ID: 31476936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label Uses of Topical Pimecrolimus.
    Ladda M; Sandhu V; Ighani A; Yeung J
    J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Label Uses of Topical Calcineurin Inhibitors.
    Wong E; Kurian A
    Skin Therapy Lett; 2016 Jan; 21(1):8-10. PubMed ID: 27224898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative use of topical calcineurin inhibitors.
    Lin AN
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Off-label indications for topical tacrolimus].
    Hengge UR
    Hautarzt; 2013 Oct; 64(10):752-6. PubMed ID: 24150824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
    Wollina U
    Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical calcineurin inhibitors in lichen planus.
    Samycia M; Lin AN
    J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Topical Calcineurin Inhibitors in Oral Lichen Planus.
    Sotoodian B; Lo J; Lin A
    J Cutan Med Surg; 2015; 19(6):539-45. PubMed ID: 26088501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label uses of topical vitamin D in dermatology: a systematic review.
    Wat H; Dytoc M
    J Cutan Med Surg; 2014; 18(2):91-108. PubMed ID: 24636434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT; Thaçi D; Luger T
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
    Hong CH; Gooderham M; Bissonnette R
    J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label topical calcineurin inhibitor use in children.
    Manthripragada AD; Pinheiro SP; MaCurdy TE; Saneinejad S; Worrall CM; Kelman JA; Graham DJ
    Pediatrics; 2013 Nov; 132(5):e1327-32. PubMed ID: 24127469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Role of Topical Calcineurin Inhibitors: A Pediatric Dermatology Perspective.
    Fiorillo L; Marcoux D; Ramien M
    J Cutan Med Surg; 2019; 23(4_suppl):11S-18S. PubMed ID: 31476940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential future dermatological indications for tacrolimus ointment.
    Ruzicka T; Assmann T; Lebwohl M
    Eur J Dermatol; 2003; 13(4):331-42. PubMed ID: 12948911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.